About Maze Therapeutics
Maze Therapeutics is a company based in Redwood City (United States) founded in 2018.. Maze Therapeutics has raised $496 million across 4 funding rounds from investors including Janus Henderson Investors, Piper Sandler and Driehaus. The company has 125 employees as of December 31, 2024. Maze Therapeutics operates in a competitive market with competitors including Metabolon, Alector, Seer, Tango Therapeutics and NeoPhore, among others.
- Headquarter Redwood City, United States
- Employees 125 as on 31 Dec, 2024
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Maze Therapeutics, Inc.
-
Annual Revenue
$167.5 M0as on Dec 31, 2024
-
Net Profit
$18.38 M0as on Dec 31, 2024
-
EBITDA
$60.88 M0as on Dec 31, 2024
-
Total Equity Funding
$496 M (USD)
in 4 rounds
-
Latest Funding Round
$115 M (USD), Series D
Dec 04, 2024
-
Investors
Janus Henderson Investors
& 20 more
-
Employee Count
125
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Maze Therapeutics
Maze Therapeutics is a publicly listed company on the NASDAQ with ticker symbol MAZE in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Maze Therapeutics
Maze Therapeutics has successfully raised a total of $496M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $115 million completed in December 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $115.0M
-
First Round
First Round
(01 Mar 2019)
- Investors Count 21
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2024 | Amount | Series D - Maze Therapeutics | Valuation | Deep Track Capital , Frazier Life Sciences | |
| Jan, 2022 | Amount | Series C - Maze Therapeutics | Valuation | Matrix Capital Management | |
| Oct, 2019 | Amount | Series C - Maze Therapeutics | Valuation | City Hill Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Maze Therapeutics
Maze Therapeutics has secured backing from 21 investors, including venture fund and institutional investors. Prominent investors backing the company include Janus Henderson Investors, Piper Sandler and Driehaus. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Deep Track Capital is engaged in biotechnology investment activities.
|
Founded Year | Domain | Location | |
|
Healthcare investment firm focused on novel therapeutics development.
|
Founded Year | Domain | Location | |
|
Private equity fund focused on the biotechnology sector
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Maze Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Maze Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Maze Therapeutics Comparisons
Competitors of Maze Therapeutics
Maze Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Metabolon, Alector, Seer, Tango Therapeutics and NeoPhore, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| domain | founded_year | HQ Location |
Immuno-modulatory therapies for dementia and neurodegenerative disorders are developed.
|
|
| domain | founded_year | HQ Location |
Proteomics platform developed for early cancer and neurological disease detection.
|
|
| domain | founded_year | HQ Location |
Novel cancer drugs are developed using synthetic lethality screening.
|
|
| domain | founded_year | HQ Location |
NeoPhore is focused on cancer neoantigen evolution therapies.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Maze Therapeutics
Frequently Asked Questions about Maze Therapeutics
When was Maze Therapeutics founded?
Maze Therapeutics was founded in 2018 and raised its 1st funding round 1 year after it was founded.
Where is Maze Therapeutics located?
Maze Therapeutics is headquartered in Redwood City, United States. It is registered at Redwood City, California, United States.
Who is the current CEO of Maze Therapeutics?
Jason Coloma is the current CEO of Maze Therapeutics.
Is Maze Therapeutics a funded company?
Maze Therapeutics is a funded company, having raised a total of $496M across 4 funding rounds to date.
How many employees does Maze Therapeutics have?
As of Dec 31, 2024, the latest employee count at Maze Therapeutics is 125.
What is the annual revenue of Maze Therapeutics?
Annual revenue of Maze Therapeutics is $167.5M as on Dec 31, 2024.
What does Maze Therapeutics do?
Maze Therapeutics was founded in 2018 and is headquartered in Redwood City, United States. Genetic biomarkers and integrated technologies are developed to identify modifiers in neurological, metabolic, and renal diseases. Operations extend to oncology, with a focus on therapeutic applications in the biotechnology sector. Research efforts target disease mechanisms through genetic analysis.
Who are the top competitors of Maze Therapeutics?
Maze Therapeutics's top competitors include Alector, Lexicon Pharmaceuticals and Metabolon.
Is Maze Therapeutics publicly traded?
Yes, Maze Therapeutics is publicly traded on NASDAQ under the ticker symbol MAZE.
Who are Maze Therapeutics's investors?
Maze Therapeutics has 21 investors. Key investors include Janus Henderson Investors, Piper Sandler, Driehaus, Arch Venture Partners, and Deep Track Capital.
What is Maze Therapeutics's ticker symbol?
The ticker symbol of Maze Therapeutics is MAZE on NASDAQ.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.